28203 (2026). Debbie Ngarewa-Packer to the Associate Minister of Health

Written Question

Published date: 26 Jun 2026

Metadata

Document type:	Written Question
Parliament number:	54
Question number:	28203 (2026)
Question asked:	10 Jun 2026
Member asking:	Debbie Ngarewa-Packer
Portfolio:	Associate Minister of Health
Minister replying:	Hon David Seymour
Answer received:	18 Jun 2026
Status:	Question Answered
Reply type:	Reply
Document ID:	WQ_28203_2026
Document guid:	047b096d-649f-4ddf-bfa7-143e56fe04ba

28203 (2026). Debbie Ngarewa-Packer to the Associate Minister of Health: Further to WPQ 20209, why did Pharmac not undertake an equity impact assessment before proposing the removal of Māori ethnicity as an eligibility criterion for Type 2 diabetes medication?

Hon David Seymour: Pharmac makes decisions using the Factors for Consideration, which include the impact of the health condition on Māori and other population groups experiencing health disparities. A summary of this information was released as part of the consultation to support feedback on the proposed changes.